These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11943870)

  • 1. How to assess the relative importance of different colonization routes of pathogens within hospital settings.
    Pelupessy I; Bonten MJ; Diekmann O
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5601-5. PubMed ID: 11943870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative effects of barrier precautions and topical antibiotics on nosocomial bacterial transmission: results of multi-compartment models.
    Boldin B; Bonten MJ; Diekmann O
    Bull Math Biol; 2007 Oct; 69(7):2227-48. PubMed ID: 17453305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control.
    Bonten MJ; Austin DJ; Lipsitch M
    Clin Infect Dis; 2001 Nov; 33(10):1739-46. PubMed ID: 11595995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An algorithm to estimate the importance of bacterial acquisition routes in hospital settings.
    Bootsma MC; Bonten MJ; Nijssen S; Fluit AC; Diekmann O
    Am J Epidemiol; 2007 Oct; 166(7):841-51. PubMed ID: 17644823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infection control and prevention in intensive care: environmental aspects].
    Corona A; Raimondi F
    Minerva Anestesiol; 2003 Apr; 69(4):308-14. PubMed ID: 12766725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of infections caused by drug-resistant organisms in critical care.
    Hoppe B
    Am J Crit Care; 1997 Mar; 6(2):141-4. PubMed ID: 9172851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analysis of hospital infection data using hidden Markov models.
    Cooper B; Lipsitch M
    Biostatistics; 2004 Apr; 5(2):223-37. PubMed ID: 15054027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian inference of hospital-acquired infectious diseases and control measures given imperfect surveillance data.
    Forrester ML; Pettitt AN; Gibson GJ
    Biostatistics; 2007 Apr; 8(2):383-401. PubMed ID: 16926230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus?
    Nijssen S; Bonten MJ; Weinstein RA
    Clin Infect Dis; 2005 Feb; 40(3):405-9. PubMed ID: 15668864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of the emergence of bacterial resistance in the hospital environment.
    Hosein IK; Hill DW; Jenkins LE; Magee JT
    J Appl Microbiol; 2002; 92 Suppl():90S-7S. PubMed ID: 12000618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures.
    Stein GE
    Pharmacotherapy; 2005 Oct; 25(10 Pt 2):44S-54S. PubMed ID: 16178675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
    Henderson DK
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations.
    Santos RP; Mayo TW; Siegel JD
    Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and process factors affecting the implementation of antimicrobial resistance prevention and control strategies in U.S. hospitals.
    Chou AF; Yano EM; McCoy KD; Willis DR; Doebbeling BN
    Health Care Manage Rev; 2008; 33(4):308-22. PubMed ID: 18815496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stochastic mathematical model of methicillin resistant Staphylococcus aureus transmission in an intensive care unit: predicting the impact of interventions.
    McBryde ES; Pettitt AN; McElwain DL
    J Theor Biol; 2007 Apr; 245(3):470-81. PubMed ID: 17188714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of measures to assess prevention and control of AMR in hospitals.
    Flanagan M; Ramanujam R; Sutherland J; Vaughn T; Diekema D; Doebbeling BN
    Med Care; 2007 Jun; 45(6):537-44. PubMed ID: 17515781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission.
    Mammina C; Di Carlo P; Cipolla D; Giuffrè M; Casuccio A; Di Gaetano V; Plano MR; D'Angelo E; Titone L; Corsello G
    Am J Infect Control; 2007 May; 35(4):222-30. PubMed ID: 17482993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocidal textiles can help fight nosocomial infections.
    Borkow G; Gabbay J
    Med Hypotheses; 2008; 70(5):990-4. PubMed ID: 17959322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.